Companies Dominating the HVDC Converter Station Landscape
- ABB, Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Siemens AG
- General Electric Company
- XJ Group Corporation
- Bharat Heavy Electricals Limited
- Alstom SA
- Nissin Electric Co Ltd.
- Toshiba Corporation
- Hitachi Ltd.
- C-EPRI Electric Power Engineering Co. Ltd
Browse Key Market Insights with Data Illustration:
In the News
-
IBSRELA, the first and only NHE3 inhibitor for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults, is now available from the biopharmaceutical company Ardelyx. The first of its Ardelyx products approved by the US Food and Drug Administration is IBSRELA.
-
Indegene, a provider of technology-driven healthcare solutions, and meta Me Health, the manufacturer of Regulora and a prescription digital therapy (PDT) company, have announced that Regulora is a drug for the treatment of stomach pain (IBS) associated with irritable bowel syndrome.
